Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SBC
SBC logo

SBC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
3.285
Open
3.285
VWAP
3.25
Vol
61.50K
Mkt Cap
336.45M
Low
3.230
Amount
199.78K
EV/EBITDA(TTM)
3.28
Total Shares
102.58M
EV
230.47M
EV/OCF(TTM)
9.34
P/S(TTM)
1.95
SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
Show More

Events Timeline

(ET)
2026-03-27
16:30:00
Major Averages Drop Due to Strait of Hormuz Incidents
select
2026-03-27
12:00:00
Major Averages Decline Amid Middle East Tensions
select
2026-03-27
06:50:00
SBC Medical Q4 Revenue at $40M, Below Consensus
select
2026-03-24 (ET)
2026-03-24
08:20:00
SBC Medical Group Launches SBC Wellness 2.0 Platform
select
2026-01-07 (ET)
2026-01-07
09:40:00
OrangeTwist Forms Strategic Alliance with SBC Medical Group Holdings
select

News

Newsfilter
9.5
05-01Newsfilter
SBC Medical Group to Release Q1 2026 Financial Results
  • Earnings Release Schedule: SBC Medical Group plans to release its financial results for the first quarter ended March 31, 2026, before the U.S. market opens on May 14, 2026, which is expected to provide investors with key financial data and operational performance insights.
  • Conference Call Details: Management will host an earnings conference call on the same day at 8:30 a.m. Eastern Time, followed by a Q&A session with analysts and investors, aimed at enhancing transparency and fostering engagement with stakeholders.
  • Company Background: SBC Medical Group is a Medical Services Organization providing management support across various healthcare fields, including aesthetic healthcare and orthopedics, actively expanding its presence in the U.S. and Asia, demonstrating its commitment to a global strategy.
  • NASDAQ Listing Achievement: Since its listing on NASDAQ in September 2024, SBC Medical Group was included in the Russell 3000® Index in June 2025, marking an increase in its recognition and influence within the U.S. equity market.
NASDAQ.COM
8.5
04-20NASDAQ.COM
SBC Medical Group Announces Pricing of Secondary Stock Offering
  • Offering Size: SBC Medical Group announced a secondary public offering of 3.1 million shares priced at $3.25 per share, expected to close around April 21, 2026, providing financial support to the founder and selling stockholder.
  • Underwriter Arrangement: Maxim Group LLC is acting as the sole book-running manager, with Roth Capital Partners as co-manager, ensuring the smooth execution of the offering and reflecting market confidence in SBC Medical.
  • Market Performance: SBC Medical's stock has traded between $2.97 and $5.75 over the past year, closing at $4.49, up 1.58% from the previous trading day, indicating optimistic investor sentiment regarding the company's future.
  • Business Diversification: SBC Medical Group operates across various medical fields, including aesthetic healthcare and orthopedics, and is committed to enhancing global well-being through medical innovation as it expands its global footprint.
seekingalpha
8.5
04-20seekingalpha
SBC Medical Group Announces Secondary Stock Offering
  • Offering Details: SBC Medical Group's founder Yoshiyuki Aikawa has announced a secondary public offering of 3.10 million shares at $3.25 per share, expected to close on April 21, 2026, which could enhance liquidity despite the company not selling any shares.
  • Underwriter Option: The underwriters have a 45-day option to purchase an additional 465,000 shares, which, if exercised, could bolster market confidence in SBC, although the company itself will not benefit from the offering.
  • Stock Price Reaction: Following the announcement of the offering, SBC Medical Group's stock plummeted nearly 12% in after-hours trading to around $3.98, indicating a negative market reaction that may impact investor sentiment.
  • Financial Performance Overview: SBC Medical Group reported a GAAP EPS of $0.14, beating estimates by $0.03, but its revenue of $39.57 million fell short of expectations by $5.87 million, highlighting challenges in revenue growth for the company.
Newsfilter
8.5
04-19Newsfilter
SBC Medical Group Announces Secondary Public Offering
  • Offering Details: SBC Medical Group is pricing a secondary public offering of 3.1 million shares at $3.25 each, expected to close on April 21, 2026, which will enhance liquidity, although the company itself is not selling any shares.
  • Underwriter Arrangement: Maxim Group LLC is acting as the sole book-running manager while Roth Capital Partners serves as co-manager, ensuring a smooth issuance process and increasing market attention on the company's stock.
  • Additional Purchase Option: The selling stockholder has granted underwriters a 45-day option to purchase an additional 465,000 shares, which may enhance demand for the stock in the market.
  • Company Background: SBC Medical Group is a Management Services Organization operating across various medical fields, actively expanding its presence in the U.S. and Asia, committed to enhancing global well-being through medical innovation and strengthening its international reputation.
Globenewswire
8.5
03-31Globenewswire
SBC Medical Group's Global Expansion Strategy
  • Revenue Growth Signal: SBC Medical Group reported an 11% year-over-year increase in average revenue per visit to $316 in Q4 2025, indicating a recovery after several quarters of compression, which enhances investor confidence in the company's financial health.
  • U.S. Market Expansion: The minority investment in OrangeTwist marks SBC Medical's official entry into the U.S. market, a crucial step in its global expansion strategy that is expected to enhance brand visibility and increase market share.
  • High-Profit Business Model: With over 40% EBITDA margins across a network of 283 locations and 6.63 million annual patient visits, SBC Medical's capital-light business model demonstrates effectiveness, providing robust support for future expansion initiatives.
  • Strong Financial Position: The company boasts $164 million in cash and low leverage, offering flexibility for M&A and continued expansion, which supports its SBC Wellness 2.0 initiative in Japan's $34 billion longevity market.
Newsfilter
8.5
03-31Newsfilter
SBC Medical Group's Global Expansion Strategy
  • Revenue Growth Signal: SBC Medical Group's average revenue per visit increased by 11% year-over-year to $316 in Q4, indicating a recovery in unit economics after several quarters of compression, which suggests potential improvements in future profitability.
  • U.S. Market Expansion: By making a minority investment in OrangeTwist, SBC Medical officially enters the U.S. market, a strategic move that not only broadens its global business footprint but also lays the groundwork for its presence in the competitive U.S. aesthetic market.
  • Efficient Business Model: The company has achieved EBITDA margins exceeding 40% across a network of 283 locations, demonstrating the success of its capital-light business model while catering to 6.63 million annual patient visits, thus ensuring operational efficiency.
  • Long-term Growth Plans: SBC Medical aims to leverage AI-driven operational infrastructure and expand SBC Wellness 2.0 into Japan's $34 billion longevity market, showcasing its forward-looking strategy in the global healthcare services sector.
Wall Street analysts forecast SBC stock price to rise
1 Analyst Rating
Wall Street analysts forecast SBC stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
BTIG
Sam Eiber
initiated
$8
AI Analysis
2026-03-06
Reason
BTIG
Sam Eiber
Price Target
$8
AI Analysis
2026-03-06
initiated
Reason
BTIG analyst Sam Eiber initiated coverage of SBC Medical Group with a Buy rating and $8 price target. SBC is the leading aesthetic medical group in Japan with more than 250 franchises and over 6.5M annual patient visits, the analyst tells investors in a research note. The firm says the shares represent an opportunity for investors looking to own an outside of the U.S. business that has "numerous growth prospects" and is trading at a discount to peers.
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SBC
Unlock Now

Valuation Metrics

The current forward P/E ratio for SBC Medical Group Holdings Inc (SBC.O) is 7.09, compared to its 5-year average forward P/E of 4.25. For a more detailed relative valuation and DCF analysis to assess SBC Medical Group Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
4.25
Current PE
7.09
Overvalued PE
8.34
Undervalued PE
0.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.69
Current EV/EBITDA
3.41
Overvalued EV/EBITDA
2.14
Undervalued EV/EBITDA
-0.76

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.27
Current PS
1.72
Overvalued PS
2.44
Undervalued PS
0.09

Financials

AI Analysis
Annual
Quarterly

Whales Holding SBC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SBC Medical Group Holdings Inc (SBC) stock price today?

The current price of SBC is 3.23 USD — it has decreased -1.52

What is SBC Medical Group Holdings Inc (SBC)'s business?

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

What is the price predicton of SBC Stock?

Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SBC Medical Group Holdings Inc (SBC)'s revenue for the last quarter?

SBC Medical Group Holdings Inc revenue for the last quarter amounts to 39.57M USD, decreased -10.93

What is SBC Medical Group Holdings Inc (SBC)'s earnings per share (EPS) for the last quarter?

SBC Medical Group Holdings Inc. EPS for the last quarter amounts to 0.14 USD, increased 133.33

How many employees does SBC Medical Group Holdings Inc (SBC). have?

SBC Medical Group Holdings Inc (SBC) has 863 emplpoyees as of May 06 2026.

What is SBC Medical Group Holdings Inc (SBC) market cap?

Today SBC has the market capitalization of 336.45M USD.